Antioxidants for chronic kidney disease (Q24198197)

6

object named as

Toshiharu Ninomiya

0 references

Angela Webster

7

object named as

Angela C Webster

0 references

Vlado Perkovic

8

0 references

Mona Razavian

3

object named as

Mona Razavian

0 references

author name string

Min Jun

1

0 references

Vinod Venkataraman

2

0 references

Bruce Cooper

Cochrane Database of Systematic Reviews

4

0 references

publication date

17 October 2012

0 references

published in

0 references

cites work

Bardoxolone methyl and kidney function in CKD with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Effects of vitamin E on cardiovascular outcomes in people with mild-to-moderate renal insufficiency: results of the HOPE study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

The HOPE (Heart Outcomes Prevention Evaluation) Study and its consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

The antioxidant acetylcysteine reduces cardiovascular events in patients with end-stage renal failure: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Effect of a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on carotid intima-media thickness, endothelial function, and renal function in patients with mild to moderate chronic kidney disease: results from the Ant

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Effects of antioxidant supplementation on blood cyclosporin A and glomerular filtration rate in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

L-arginine deficiency and supplementation in experimental acute renal failure and in human kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

A randomized, controlled trial of early versus late initiation of dialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Effect of dialysis dose and membrane flux in maintenance hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Ascorbate is an outstanding antioxidant in human blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Quality of Reporting of Randomized Trials as a Measure of Methodologic Quality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

The oxygen free radical system: from equations through membrane-protein interactions to cardiovascular injury and protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Dietary flax seed in prevention of hypercholesterolemic atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Role of immunocompetent cells in nonimmune renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Preventi

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

The role of oxidative stress in the genesis of heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

A comparison of sevelamer and calcium-based phosphate binders on mortality, hospitalization, and morbidity in hemodialysis: a secondary analysis of the Dialysis Clinical Outcomes Revisited (DCOR) randomized trial using claims data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

AGEs and carbonyl stress: potential pathogenetic factors of long-term uraemic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Antioxidants for chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Effect of hemodialysis on lipid peroxidation and antioxidant system in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Effects of N-acetylcysteine in the rat heart reperfused after low-flow ischemia: evidence for a direct scavenging of hydroxyl radicals and a nitric oxide-dependent increase in coronary flow

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Effects of pentoxifylline treatment on delayed graft function in cadaveric kidney recipients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

A multivitamin infusion prevents lipid peroxidation and improves transplantation performance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Plasma protein thiol oxidation and carbonyl formation in chronic renal failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Vitamin E supplementation and cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Effect of alpha-tocopherol on in vitro and in vivo metabolism of low-density lipoproteins in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

A randomized double-blind trial of the use of human recombinant superoxide dismutase in renal transplantation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Immunomodulatory effect of pentoxifylline during human allograft rejection: involvement of tumor necrosis factor-alpha and adhesion molecules

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Role of free radicals in catecholamine-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Canine myocardial reperfusion injury. Its reduction by the combined administration of superoxide dismutase and catalase.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Depending on their concentration oxidized low density lipoproteins stimulate extracellular matrix synthesis or induce apoptosis in human coronary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Microalbuminuria as an early marker for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021

Alterations in free radical tissue-defense mechanisms in streptozocin-induced diabetes in rat. Effects of insulin treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008176.PUB2

7 January 2021